Sonoma Pharmaceuticals (STU:O8Z) Accounts Payable & Accrued Expense : €2.77 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sonoma Pharmaceuticals Accounts Payable & Accrued Expense?

Sonoma Pharmaceuticals's quarterly accounts payable & accrued expense declined from Dec. 2023 (€2.49 Mil) to Mar. 2024 (€1.86 Mil) but then increased from Mar. 2024 (€1.86 Mil) to Jun. 2024 (€2.77 Mil).

Sonoma Pharmaceuticals's annual accounts payable & accrued expense declined from Mar. 2022 (€2.45 Mil) to Mar. 2023 (€2.15 Mil) and declined from Mar. 2023 (€2.15 Mil) to Mar. 2024 (€1.86 Mil).

Sonoma Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sonoma Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoma Pharmaceuticals Accounts Payable & Accrued Expense Chart

Sonoma Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.48

2.46

2.45

2.15

1.86

Sonoma Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.09	2.52	2.49	1.86	2.77

Sonoma Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sonoma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sonoma Pharmaceuticals Inc (STU:O8Z) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SNOA:USA O8Z3:Germany

Address

5445 Conestoga Court, Suite 150, Boulder, CO, USA, 80301

Website

https://www.sonomapharma.com

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Sonoma Pharmaceuticals Headlines

No Headlines